Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2022-04-22 AGM Information
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
KOLINPHARMA,AVVISO CORTESIA PER LA PARTECIPAZIONE ASSEMBLEA AZIONISTI
AGM Information Classification · 1% confidence The document is an official notice from KOLINPHARMA S.p.A. dated April 22, 2022, titled 'Avviso di cortesia per la partecipazione all'Assemblea degli Azionisti' (Courtesy notice for participation in the Shareholders' Meeting). It explicitly mentions the dates for the first and second calls of the Shareholders' Meeting (Assemblea degli Azionisti). This type of communication, which provides information or courtesy notice regarding an upcoming general meeting, aligns best with the 'AGM Information' category, even though it is a courtesy notice rather than the full presentation materials. The key subject is the 'Assemblea Azionisti'.
2022-04-22 Italian
Kolinpharma, acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" and the subject is "Kolinpharma, acquisto azioni proprie" (Kolinpharma, purchase of own shares). It details the execution of a share buyback program for the period April 11-15, 2022, including the number of shares purchased and the total consideration. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a price-sensitive communication, the core subject matter is the share repurchase, making POS the most specific classification over a general Regulatory Filing (RNS) or Report Publication Announcement (RPA), as it is the report/disclosure itself, not just an announcement that a report is available.
2022-04-20 Italian
KOLINPHARMA, acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled "COMUNICATO STAMPA PRICE SENSITIVE" and the subject is "Comunicazione sullo stato di attuazione del Programma di acquisto azioni proprie" (Communication on the status of implementation of the share buyback program). It details the purchase of 1,200 own shares during the period April 4 - April 8, 2022. This activity—the reporting of a company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a press release, the core content is the transaction report, making POS more specific than a general RPA or RNS.
2022-04-08 Italian
KOLINPHARMA, pubblicazione avviso convocazione Assemblea ordinaria Azionisti 2022 e allegati
AGM Information Classification · 1% confidence The document is titled 'AVVISO DI CONVOCAZIONE' (Notice of Meeting) for an 'Assemblea ordinaria degli Azionisti' (Ordinary Shareholders' Meeting) of KOLINPHARMA S.P.A. It specifies the date (April 28, 2022, and May 6, 2022, for the second call) and the agenda, which includes the approval of the financial statements and other corporate resolutions. The document also details the procedures for remote voting via a Designated Representative, which is typical for meeting notices, especially under specific regulatory conditions (like COVID-19 measures mentioned). This content strongly indicates a formal announcement related to a shareholders' meeting, which aligns best with the 'AGM Information' category, as the meeting is an Ordinary General Meeting (Assemblea Ordinaria). Although it is a notice, the core subject is the meeting itself, making AGM-R more specific than RPA or RNS.
2022-04-07 Italian
KOLINPHARMA buy-back, schema riepilogo operazioni mese di marzo
Transaction in Own Shares Classification · 1% confidence The document is an official filing from KOLINPHARMA, dated April 7, 2022, titled 'KOLINPHARMA buy-back, schema riepilogo operazioni mese di marzo' (KOLINPHARMA buy-back, summary scheme of operations for the month of March). It contains detailed tables structured under 'SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE' (Disclosure Model for Transactions in the Issuer's Securities) and specifically details daily and summary breakdowns of share transactions (purchases/sales) during March 2022. This content directly corresponds to the reporting requirements for a company buying back or selling its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2022-04-07 Italian
KOLINPHARMA, Acquisto azioni proprie
Transaction in Own Shares Classification · 1% confidence The document is titled 'Comunicato stampa price sensitive' and the subject is 'KOLINPHARMA, Acquisto azioni proprie' (Share buyback). It details the number of shares purchased, the average price, and the total consideration for the period March 28 to April 1, 2022. This is a regulatory disclosure concerning the company's own shares transactions. This directly corresponds to the definition for 'Transaction in Own Shares' (Code: POS). Although it is a price-sensitive communication, the core content is the share repurchase activity.
2022-04-01 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.